Inventor · disambiguated record
Reena Varkey
Also filed as: VARKEY REENA · VARKEY REENA M
12 granted patents·12 pending applications·48 citations·filing 2012–2025
88Inventor score
Top patents by PatentIndex Score
24 records- 0192US10988546B2BCMA monoclonal antibody-drug conjugateMEDIMMUNE LLC·Filed 2018·Granted Apr 27, 2021·8 cites·14 claims
- 0290US11203633B2Polynucleotides encoding antibodies or antigen binding fragments thereof that bind pseudomonas pervMEDIMMUNE LTD·Filed 2020·Granted Dec 21, 2021·2 cites·25 claims
- 0389US9580509B2Multispecific and multivalent binding proteins and uses thereofMEDIMMUNE LLC·Filed 2012·Granted Feb 28, 2017·9 cites·18 claims
- 0487US9527905B2Antibodies that specifically bind Staphylococcus aureus alpha toxin and methods of useSELLMAN BRET·Filed 2012·Granted Dec 27, 2016·23 cites·9 claims
- 0581US10597439B2Combination therapies using anti-pseudomonas PSL and PCRV binding moleculesMEDIMMUNE LLC·Filed 2012·Granted Mar 24, 2020·4 cites·7 claims
- 0677US12428473B2Combination therapies using anti-pseudomonas PSL and PCRV binding moleculesMEDIMMUNE LTD·Filed 2021·Granted Sep 30, 2025·0 cites·20 claims
- 0776US2024294666A1BCMA Monoclonal Antibody-Drug ConjugateMEDIMMUNE LLC·Filed 2024·Application pending·0 cites
- 0875US2023201346A1Binding molecules specific for il-21 and uses thereofBOSTON PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0973US10022443B2Antibodies specific for IL-21 and uses thereofBOSTON PHARMACEUTICALS INC·Filed 2015·Granted Jul 17, 2018·1 cites·17 claims
- 1072US2025243262A1Combination therapies using anti-pseudomonas psl and pcrv binding moleculesMEDIMMUNE LTD·Filed 2025·Application pending·0 cites
- 1170US10775388B2Methods of using antibodies to determine periostin levels in a sampleMEDIMMUNE LLC·Filed 2015·Granted Sep 15, 2020·1 cites·23 claims
- 1269US11912782B2BCMA monoclonal antibody-drug conjugateMEDIMMUNE LLC·Filed 2021·Granted Feb 27, 2024·0 cites·19 claims
- 1367US11529415B2Antibodies specific for IL-21 and uses thereofBOSTON PHARMACEUTICALS INC·Filed 2020·Granted Dec 20, 2022·0 cites·14 claims
- 1467US10588969B2Antibodies specific for IL-21 and uses thereofBOSTON PHARMACEUTICALS INC·Filed 2018·Granted Mar 17, 2020·0 cites·14 claims
- 1566US2024182548A1Sars-cov-2 antibodies and methods of selecting and using the sameASTRAZENECA UK LTD·Filed 2023·Application pending·0 cites
- 1665US2024092875A1Sars-cov-2 antibodies for treatment and prevention of covid-19ASTRAZENECA UK LTD·Filed 2023·Application pending·0 cites
- 1756US2022041694A1Sars-cov-2 antibodies for treatment and prevention of covid-19ASTRAZENECA UK LTD·Filed 2021·Application pending·0 cites
- 1855US9862762B2Monoclonal antibodies which bind human periostinMEDIMMUNE LLC·Filed 2015·Granted Jan 9, 2018·0 cites·18 claims
- 1955US2018179272A1Novel assay to detect human periostinMEDIMMUNE LLC·Filed 2017·Application pending·0 cites
- 2055US2021355196A1Sars-cov-2 antibodies and methods of selecting and using the sameASTRAZENECA UK LTD·Filed 2021·Application pending·0 cites
- 2148US2023279078A1Sars-cov-2 proteins, anti-sars-cov-2 antibodies, and methods of using the sameASTRAZENECA UK LTD·Filed 2021·Application pending·0 cites
- 2248US2017114151A1Multispecific and multivalent binding proteins and uses thereofMEDIMMUNE LLC·Filed 2016·Application pending·0 cites
- 2345US2015284450A1Combination therapies using anti-pseudomonas psl and pcrv binding moleculesMEDIMMUNE LLC·Filed 2013·Application pending·0 cites
- 2436US2017183397A1Multi-specific anti-pseudomonas psl and pcrv binding molecules and uses thereofMEDIMMUNE LLC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →